More about our work
ICR researchers working with our partner hospital The Royal Marsden NHS Foundation Trust have led major international clinical trials of new drugs that have changed the standard of care in neuroblastoma, the most commonly fatal solid tumours in children. Neuroblastoma also continues to be a major focus for our scientists in the laboratory.
A new generation of researchers is making strides towards new treatments for relatively under-studied, rarer cancers affecting children and young adults – including high grade gliomas, including glioblastoma and DIPG, rhabdomyosarcoma, Ewing’s sarcoma, osteosarcoma, malignant rhabdoid tumour and desmoplastic small round cell tumour.
Our research into these tumours is often carried out thanks to the support of our network of passionate family charity partners, who have directly experienced the devastating impact of childhood cancer and whose fundraising efforts are leading, through research at the ICR, to unprecedented insights into these diseases.